Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › April › 16
Dexcom
15 months ago
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.
page 1 of 1